| Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells L Zhuang, J Lin, ML Lu, KR Solomon, MR Freeman Cancer research 62 (8), 2227-2231, 2002 | 387 | 2002 |
| The phosphatidylinositol 3′-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells J Lin, RM Adam, E Santiestevan, MR Freeman Cancer research 59 (12), 2891-2897, 1999 | 313 | 1999 |
| Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a … ER Plimack, JH Hoffman-Censits, R Viterbo, EJ Trabulsi, EA Ross, ... Journal of clinical oncology 32 (18), 1895-1901, 2014 | 292 | 2014 |
| Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth J Lin, MC Haffner, Y Zhang, BH Lee, WN Brennen, J Britton, SK Kachhap, ... The Prostate 71 (4), 333-343, 2011 | 215 | 2011 |
| Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor SK Kachhap, N Rosmus, SJ Collis, MSQ Kortenhorst, MD Wissing, ... PloS one 5 (6), e11208, 2010 | 186 | 2010 |
| Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience LG Gomella, J Lin, J Hoffman-Censits, P Dugan, F Guiles, CD Lallas, ... Journal of oncology practice 6 (6), e5-e10, 2010 | 122 | 2010 |
| Effects of cancer stage and treatment differences on racial disparities in survival from colon cancer: a United States population-based study Y Lai, C Wang, JM Civan, JP Palazzo, Z Ye, T Hyslop, J Lin, RE Myers, ... Gastroenterology 150 (5), 1135-1146, 2016 | 114 | 2016 |
| A phase I dose-finding study of 5-azacytidine in combination with sodium phenylbutyrate in patients with refractory solid tumors J Lin, J Gilbert, MA Rudek, JA Zwiebel, S Gore, A Jiemjit, M Zhao, ... Clinical Cancer Research 15 (19), 6241-6249, 2009 | 97 | 2009 |
| BAG-1 is a novel cytoplasmic binding partner of the membrane form of heparin-binding EGF-like growth factor: a unique role for proHB-EGF in cell survival regulation J Lin, L Hutchinson, SM Gaston, G Raab, MR Freeman Journal of Biological Chemistry 276 (32), 30127-30132, 2001 | 83 | 2001 |
| Transcriptomic profiling of Aspergillus flavus in response to 5-azacytidine JQ Lin, XX Zhao, QQ Zhi, M Zhao, ZM He Fungal Genetics and Biology 56, 78-86, 2013 | 81 | 2013 |
| Indoleamine 2, 3-dioxygenase (IDO): biology and target in cancer immunotherapies S R Selvan, J P Dowling, W K Kelly, J Lin Current cancer drug targets 16 (9), 755-764, 2016 | 76 | 2016 |
| Bisulfite sequencing reveals that Aspergillus flavus holds a hollow in DNA methylation SY Liu, JQ Lin, HL Wu, CC Wang, SJ Huang, YF Luo, JH Sun, JX Zhou, ... PloS one 7 (1), e30349, 2012 | 70 | 2012 |
| An embedded 0.8 V/480/spl mu/W 6b/22 MHz flash ADC in 0.13-/spl mu/m digital CMOS process using a nonlinear double interpolation technique J Lin, B Haroun IEEE Journal of Solid-State Circuits 37 (12), 1610-1617, 2002 | 68 | 2002 |
| Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer MT Schweizer, J Lin, A Blackford, A Bardia, S King, AJ Armstrong, ... Prostate cancer and prostatic diseases 16 (4), 357-361, 2013 | 66 | 2013 |
| A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naive prostate … J Lin, M Zahurak, TM Beer, CJ Ryan, G Wilding, P Mathew, M Morris, ... Urologic Oncology: Seminars and Original Investigations 31 (5), 581-588, 2013 | 66 | 2013 |
| Transactivation of ErbB1 and ErbB2 receptors by angiotensin II in normal human prostate stromal cells J Lin, MR Freeman The Prostate 54 (1), 1-7, 2003 | 62 | 2003 |
| Heparin-binding EGF-like growth factor is up-regulated in the obstructed kidney in a cell-and region-specific manner and acts to inhibit apoptosis HT Nguyen, SH Bride, AB Badawy, RM Adam, J Lin, A Orsola, PD Guthrie, ... The American journal of pathology 156 (3), 889-898, 2000 | 61 | 2000 |
| Changes in PSA kinetics predict metastasis‐free survival in men with PSA‐recurrent prostate cancer treated with nonhormonal agents: Combined analysis of 4 phase II trials ES Antonarakis, ML Zahurak, J Lin, D Keizman, MA Carducci, ... Cancer 118 (6), 1533-1542, 2012 | 60 | 2012 |
| A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinoma RM Adam, T Danciu, DL McLellan, JG Borer, J Lin, D Zurakowski, ... Cancer research 63 (2), 484-490, 2003 | 60 | 2003 |
| Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function RM Adam, J Kim, J Lin, A Orsola, L Zhuang, DC Rice, MR Freeman* Endocrinology 143 (12), 4599-4608, 2002 | 59 | 2002 |
